Eric Giesing Joins Savillex as Chief Executive Officer
Savillex is pleased to announce the appointment of Eric Giesing as Chief Executive Officer. An accomplished leader with broad expertise in life sciences, Giesing has previously held leadership positions during pivotal growth periods for numerous life sciences companies. He most recently served as Chief Commercial Officer at Fortis Life Science and has had a variety of management roles at Danaher Corporation.
Bioprocess production and supply in pandemic times
The bioprocess industry isn’t immune to supply chain challenges These pandemic times have stretched global supply chains to their breaking point. And as a result, the bioprocess industry has been attempting to overcome several major hurdles. Chief among them is a shortage in key components like piping, filters, diaphragms and
Profiling fluoropolymer bottle extractables
Understanding the impact of container extractables When choosing containers for applications such as critical drug substances, cell therapies and regenerative medicines, it’s important to consider the effect extractables can have on products. Extractables are the organic or inorganic chemical compounds released from container systems when faced with aggressive laboratory conditions
Getting “Closure” on Bottle Torque and Seal Integrity
Balancing Container Integrity and Closure Torque Applications like cell therapies and regenerative medicines demand absolute container integrity to ensure product sterility. To that end, bottles, vials, sample jars, and other rigid containers tend to be the natural choice due to their durable construction and strong closure systems. However, another key
Interphex 2021 Recap
By Eric Isberg, VP of Life Sciences Obsvervations and Trends of Interphex 2021 We attended Interphex in NYC as our second live show of the 2021 season. Interphex remains the “who’s who” in the bioprocessing world, with over 500 exhibitors and thousands of attendees. Although a noticeably quieter show than
Breaking down the benefits of family and multi-cavity tooling
Can your project benefit from multi-cavity or family tooling? Injection molding fluoropolymers can be a very challenging process due to the nature of the polymers themselves. For one – fluoropolymers have extremely high melting points and produce corrosive HF gas when molten. High shrink rates also add to the challenges.
Sights, Sounds and Learnings from the ISPE Boston Product Show
By Eric Isberg, VP of Life Sciences Sights and Sounds It was great to be back at a live show and face-to-face with our customers again. The ISPE Boston Product Show, which represents an area of the US with over 60% of the active bioprocess projects, proved once again that
Phacilitate Advanced Therapies Week 2022 Recap
By Drew Carlson, Applications Development Manager – Life Sciences Conversations and Collaboration Advanced Therapies Week,
Bioprocess production and supply in pandemic times
The bioprocess industry isn’t immune to supply chain challenges These pandemic times have stretched global
Profiling fluoropolymer bottle extractables
Understanding the impact of container extractables When choosing containers for applications such as critical drug
Getting “Closure” on Bottle Torque and Seal Integrity
Balancing Container Integrity and Closure Torque Applications like cell therapies and regenerative medicines demand absolute
Interphex 2021 Recap
By Eric Isberg, VP of Life Sciences Obsvervations and Trends of Interphex 2021 We attended
Breaking down the benefits of family and multi-cavity tooling
Can your project benefit from multi-cavity or family tooling? Injection molding fluoropolymers can be a